Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on EquityTimes Interest Earned

Preaxia Health Care Payment Systems (PAXH) Return on Sales (2021 - 2023)

Preaxia Health Care Payment Systems (PAXH) has disclosed Return on Sales for 3 consecutive years, with 6206.93% as the latest value for Q1 2023.

  • Quarterly Return on Sales fell 553841.0% to 6206.93% in Q1 2023 from the year-ago period, while the trailing twelve-month figure was 6206.93% through Feb 2023, down 593309.0% year-over-year, with the annual reading at 490.88% for FY2022, 9381.0% down from the prior year.
  • Return on Sales hit 6206.93% in Q1 2023 for Preaxia Health Care Payment Systems, down from 1833.97% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 138.86% in Q2 2021 to a low of 6206.93% in Q1 2023.
  • Historically, Return on Sales has averaged 1413.63% across 3 years, with a median of 668.51% in 2022.
  • Biggest five-year swings in Return on Sales: soared 47335bps in 2022 and later tumbled -553841bps in 2023.
  • Year by year, Return on Sales stood at 189.8% in 2021, then tumbled by -866bps to 1833.97% in 2022, then crashed by -238bps to 6206.93% in 2023.
  • Business Quant data shows Return on Sales for PAXH at 6206.93% in Q1 2023, 1833.97% in Q4 2022, and 539.63% in Q3 2022.